Florida Cancer Innovation Fund 2026–2027

Florida Cancer Innovation Fund 2026–2027

Due Date: 12/18/2026

The Florida Cancer Innovation Fund 2026–2027, administered by the Florida Department of Health, supports one-year projects designed to produce measurable improvements in cancer research or care. Its final application period is currently open.

The program prioritizes research that can move quickly toward clinical use, including early diagnostics, treatment studies and approaches that improve access or affordability. Proposals must set measurable goals and explain how their results could benefit patients across Florida. Cancer Applicants Process

Eligibility and Project Criteria

  • Applicants must be eligible Florida-based institutions meeting at least one of the sponsor’s healthcare, biomedical research or training criteria.
  • The principal investigator must be employed by the applicant institution and meet its requirements for leading research.
  • The principal investigator must be a U.S. citizen or permanent resident.
  • Funded work and expenditure must generally remain in Florida; limited exceptions require sponsor approval.
  • Projects must be completed within 12 months.
  • Each principal investigator may submit only one application during the fiscal-year cycle, and a project cannot enter multiple grant categories.

Funding Details

  • Total program funding: Approximately US$70 million across the 2026–2027 competition.
  • Project duration: 12 months.
  • Funding categories include rapid translation, consortia, clinical trials and pilot studies.
  • Awards depend on available appropriations and spending authority.

Deadline

  • Final-round application deadline: December 18, 2026.
  • Applications are submitted through the Florida Cancer Innovation Fund portal.

Further Information